Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amiloride pharmacokinetics in rat

G Segre1, D Cerretani, G Bruni

  • 1Istituto di Farmacologia, University of Siena, Italy.

European Journal of Drug Metabolism and Pharmacokinetics
|September 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson in the bb[over ¯] Final State Using pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Magnetic Monopole Pair Production in Ultraperipheral Pb+Pb Collisions at sqrt[s_{NN}]=5.36  TeV with the ATLAS Detector at the LHC.

Physical review letters·2025

This study details amiloride

Area of Science:

  • Pharmacokinetics
  • Drug Metabolism and Disposition

Background:

  • Amiloride is a potassium-sparing diuretic.
  • Understanding amiloride's distribution and elimination is crucial for therapeutic use.

Purpose of the Study:

  • To investigate the pharmacokinetic profile of amiloride in rats.
  • To develop a compartmental model for amiloride kinetics.
  • To predict amiloride behavior during continuous intravenous infusion.

Main Methods:

  • Oral and intravenous administration of amiloride in rats.
  • Analysis of amiloride concentrations in plasma, urine, feces, and tissues.
  • Development and application of a multiexponential and compartmental pharmacokinetic model.

Main Results:

Related Experiment Videos

  • Experimental data were initially analyzed using a multiexponential model.
  • A compartmental model successfully described amiloride kinetics after oral and IV bolus administration.
  • Model predictions for continuous infusion revealed insights into amiloride's pharmacokinetic behavior.

Conclusions:

  • The developed compartmental model provides a robust framework for understanding amiloride pharmacokinetics.
  • Discrepancies between predicted and observed data enhance the understanding of amiloride's disposition.
  • This research offers valuable insights into amiloride's behavior in various physiological compartments.